Ruta Kulkarni
Biographic Data
| ID | 10035976 |
|---|---|
| NAME | Ruta Kulkarni |
| GIVEN NAMES | Ruta |
| FAMILY NAME | Kulkarni |
| SIGNATURE | KULKARNI R |
| AFFILIATIONS | Bharati Vidyapeeth Deemed University |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Dengue in Pune city, India (2017–2019)
Objectives: To understand the dynamics of dengue disease with special reference to (1) age (2) primary/secondary infections (3) serostatus and (4) serotypes examined during three consecutive years. Methods: During 3 dengue seasons (2017-19), NS1/IgM ELISAs were used for dengue diagnosis in one of the 15 administrative wards of Pune City, India. Predefined symptoms were recorded at the time of diagnosis/hospitalization. IgG-capture ELISA (Panbio) …
Sars-CoV-2 breakthrough infections during the second wave of Covid-19 at Pune, India
Breakthrough infections following SARS-CoV-2 vaccination remain the global concern. The current study was conducted during the second wave of COVID-19 (1st March−7th July 2021) in Pune, India, at two tertiary care hospitals. Of the 6,159 patients diagnosed as COVID-19, 372/2,210 (16.8%) were breakthrough infections. Of these, 81.1 and 18.8% received one or two doses of Covishield or Covaxin, respectively. Of note, 30.7% patients were with comorbi…
No prominent works on this page.
Sars-CoV-2 breakthrough infections during the second wave of Covid-19 at Pune, India
Breakthrough infections following SARS-CoV-2 vaccination remain the global concern. The current study was conducted during the second wave of COVID-19 (1st March−7th July 2021) in Pune, India, at two tertiary care hospitals. Of the 6,159 patients diagnosed as COVID-19, 372/2,210 (16.8%) were breakthrough infections. Of these, 81.1 and 18.8% received one or two doses of Covishield or Covaxin, respectively. Of note, 30.7% patients were with comorbi…
Dengue in Pune city, India (2017–2019)
Objectives: To understand the dynamics of dengue disease with special reference to (1) age (2) primary/secondary infections (3) serostatus and (4) serotypes examined during three consecutive years. Methods: During 3 dengue seasons (2017-19), NS1/IgM ELISAs were used for dengue diagnosis in one of the 15 administrative wards of Pune City, India. Predefined symptoms were recorded at the time of diagnosis/hospitalization. IgG-capture ELISA (Panbio) …
Medicine (2 works) · Virology (2 works) · Antibody (1 work) · Arbovirus (1 work) · Biological Research and Disease Studies (1 work) · Comorbidity (1 work) · COVID-19 Clinical Research Studies (1 work) · Dengue fever (1 work) · Dengue virus (1 work) · Disease (1 work)